| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.4M | — | +26.2% |
| Cost of Revenue | $719K | — | -14.1% |
| Gross Profit | $1.7M | — | +57.8% |
| R&D Expense | $1.7M | — | +214.2% |
| SG&A Expense | $4.5M | — | +26.5% |
| Operating Income | -$4.6M | — | -49.3% |
| Pre-tax Income | -$4.5M | — | -50.7% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$4.5M | — | -50.7% |
| EPS (Basic) | -$2.19 | — | -217.4% |
| EPS (Diluted) | -$2.19 | — | -217.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.1M | +92.0% | -18.5% |
| Accounts Receivable | $1.6M | +4.4% | +1.2% |
| Inventory | $1.8M | -6.9% | +1.5% |
| Current Assets | $5.8M | +12.4% | -4.8% |
| Total Assets | $7.0M | +13.8% | -0.6% |
| Current Liabilities | $3.7M | +23.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.1M | — | -22.7% |
| Capital Expenditures | $30K | — | — |
| Investing Cash Flow | -$284K | — | — |
| Financing Cash Flow | $4.4M | — | — |
| Free Cash Flow | -$3.1M | — | -23.9% |
| +35.7% |
| Total Liabilities | $4.3M | +23.1% | +25.4% |
| Stockholders' Equity | $2.7M | +1.4% | -25.6% |